Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP7

DAVIAD

Project ID: 602779
Financé au titre de

The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease

De 2013-12-01 à 2018-06-30, projet en cours | DAVIAD Site web

Détails concernant le projet

Coût total:

EUR 8 362 660,60

Contribution de l'UE:

EUR 5 924 893

Coordonné à/au(x)/en:

Belgium

Appel à propositions:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Régime de financement:

CP-FP - Small or medium-scale focused research project

Objectif

Coordinateur

APITOPE INTERNATIONAL NV
Belgium

Contribution de l'UE: EUR 3 539 839,50


AGORALAAN A BIS
3590 DIEPENBEEK
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Luc Lammens
Tél.: +32 499 52 54 52
Fax: +32 11 28 69 09

Contact the organisation

Participants

QUINTILES BENEFIT FRANCE INC
France

Contribution de l'UE: EUR 885 609


RUE MAURICE RAVEL 3/5
92594 LEVALLOIS PERRET CEDEX
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Gary Johnson
Tél.: +33 450449465
Fax: +33 450449465

Contact the organisation

KWS BIOTEST LIMITED
United Kingdom

Contribution de l'UE: EUR 1 484 683,50


MEDICAL SCIENCES BUILDING UNIVERSITY WALK
BS8 1TD BRISTOL
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Neil Williams
Tél.: +44 1179287886
Fax: +44 1179287896

Contact the organisation

GlaxoSmithKline Biologicals S.A
Fin de participation
Belgium

Contribution de l'UE: EUR 14 761


Rue de l’Institut
1330 Rixensart
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Philippe Denoel
Tél.: +3226564032

Contact the organisation

Thèmes

Life Sciences